Quotient Wealth Partners, TritonPoint Wealth Form Joint Partnership with Opto Investments to Institutionalize Private Markets Programs

Quotient Wealth Partners ("Quotient") and TritonPoint Wealth ("TritonPoint"), today announced a joint partnership with Opto Investments, a technology-driven solution that streamlines the entire ...

Quotient Sciences and Intrepid Labs form strategic partnership to accelerate AI-guided formulation development

Quotient Sciences, a leading global drug development, research and manufacturing accelerator, and Intrepid Labs, the AI leader in pharmaceutical formulation science, today announced a ground-breaking ...
technologynetworks

PPD and Quotient Sciences Form Innovative Partnership to Accelerate Pediatric Drug Development

The partnership leverages PPD’s pediatric clinical trial experience, regulatory knowledge, and site and pediatric patient networks, and Quotient’s expertise in pediatric formulation development, drug ...
Pharmabiz

Quotient Sciences & CPI sign MoU to form a joint venture to accelerate RNA drug development

Quotient Sciences, a leading global drug development and manufacturing accelerator, and UK technology innovation centre, CPI, have signed a memorandum of understanding (MoU) to form a joint venture ...
PR Newswire

HighTide Therapeutics and Quotient Sciences Announce Agreement to Conduct a 14C Human ADME Program for HTD1801

ROCKVILLE, Md., SHENZHEN, China and NOTTINGHAM, England, Dec. 15, 2022 /PRNewswire/ -- HighTide Therapeutics, Inc. ("HighTide"), a globally integrated clinical-stage biopharmaceutical company focusing ...